What is the management of proctitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Proctitis

For proctitis, the first-line treatment is a 1 g mesalamine (5-ASA) suppository once daily, which is the most effective therapy for mild to moderate ulcerative proctitis. 1 This approach is strongly recommended based on high-quality evidence and achieves higher mucosal drug concentrations than oral therapy alone.

Diagnosis and Initial Assessment

Before initiating treatment, it's crucial to determine the etiology of proctitis:

  • Inflammatory Bowel Disease (IBD) Proctitis: Typically presents with rectal bleeding, urgency, tenesmus, and mucous discharge
  • Infectious Proctitis: Often associated with receptive anal intercourse; common pathogens include:
    • Neisseria gonorrhoeae
    • Chlamydia trachomatis
    • Treponema pallidum
    • Herpes simplex virus 2

Diagnostic Workup

  • Anoscopy with Gram-stained smear of anorectal exudate
  • Testing for STIs: HSV (PCR/culture), N. gonorrhoeae (NAAT/culture), C. trachomatis (NAAT), T. pallidum (serology)
  • HIV testing is recommended for all patients with proctitis 1

Treatment Algorithm for Ulcerative Proctitis

Mild to Moderate Disease

  1. First-line: 1 g 5-ASA suppository once daily (preferably at night) 1
  2. If incomplete response: Add oral 5-ASA 2-3 g daily to suppository regimen
  3. If still incomplete response: Switch to or add corticosteroid suppository (e.g., 5 mg prednisolone) and continue oral 5-ASA (dose-optimize to 4-4.8 g daily)

Maintenance Therapy

  • 1 g 5-ASA suppository daily
  • Can reduce frequency to every 2nd or 3rd day or switch to oral 5-ASA to improve adherence 1

Refractory Disease

  • Oral prednisolone 40 mg once daily, weaning over 6-8 weeks
  • Consider immunomodulators or biologic therapy for induction/maintenance of remission 1

Treatment for Infectious Proctitis

For acute proctitis of recent onset in persons who have practiced receptive anal intercourse:

Recommended Regimen

  • Ceftriaxone 250 mg IM in a single dose
  • PLUS
  • Doxycycline 100 mg orally twice a day for 7 days 1

Special Considerations

  • For MSM with bloody discharge, perianal ulcers, or mucosal ulcers and positive rectal chlamydia NAAT or HIV infection: Consider extending doxycycline to 3 weeks for presumptive LGV treatment
  • If painful perianal ulcers are present: Add treatment for genital herpes 1
  • Advise patients to abstain from sexual intercourse until they and their partner(s) have completed treatment and symptoms have resolved

Important Clinical Pearls

  1. Suppositories vs. Enemas: Suppositories are preferred for proctitis as they deliver medication more effectively to the rectum and are better tolerated than enemas 1

  2. Combination Therapy: Combining topical mesalamine with oral mesalamine or topical steroids is more effective than monotherapy 1

  3. Common Pitfalls to Avoid:

    • Failing to distinguish between infectious and inflammatory causes of proctitis
    • Not considering proximal constipation, which may contribute to symptoms and poor treatment response
    • Overlooking co-existing irritable bowel syndrome
    • Missing other conditions that may cause symptoms (solitary rectal ulcer, psoriatic colitis, chemical colitis, rectal prolapse) 1
  4. Partner Management: For infectious proctitis, sexual partners within 60 days before symptom onset should be evaluated, tested, and presumptively treated 1

  5. Follow-up: For proctitis associated with gonorrhea or chlamydia, retesting should be performed 3 months after treatment 1

By following this evidence-based approach to proctitis management, clinicians can effectively treat this condition while minimizing morbidity and improving quality of life for affected patients.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.